Last month, Novo Nordisk won Food and Drug Administration approval for the first GLP-1 pill for weight loss. The medication, marketed as the Wegovy pill, is expected to be widely available this month.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback